Immediate Impact
3 from Science/Nature 73 standout
Citing Papers
Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer
2024 Standout
Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer
2023 Standout
Works of James Knowles being referenced
A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumors
2013
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| James Knowles | 36 | 31 | 48 | 435 | 240 | 14 | 746 | |
| David A. Baab | 118 | 4 | 13 | 489 | 278 | 22 | 785 | |
| W Kalk | 276 | 3 | 74 | 132 | 415 | 24 | 968 | |
| RM Palmer | 102 | 1 | 14 | 340 | 220 | 23 | 688 | |
| Hideaki Tai | 140 | 20 | 606 | 156 | 16 | 940 | ||
| Rhodri Williams | 41 | 70 | 396 | 511 | 26 | 976 | ||
| Lars Salonen | 67 | 5 | 9 | 341 | 344 | 12 | 751 | |
| Geena Koshy | 64 | 40 | 496 | 344 | 13 | 942 | ||
| Jacqueline Plemons | 164 | 2 | 37 | 395 | 200 | 23 | 781 | |
| D. F. Kinane | 141 | 14 | 552 | 216 | 22 | 801 | ||
| Martyn R. Smith | 64 | 3 | 35 | 728 | 211 | 12 | 903 |
All Works
Loading papers...